Concepedia

Jonas Rieth

JR

9

Publications

1.3K

Citations

9

H-Index

2017

Active since

Affiliations

Deutschen Konsortium für Translationale Krebsforschung(Current)

University Children's Hospital Tübingen

University of Tübingen

German Cancer Research Center

Immatics Biotechnologies (Germany)

Jonas Rieth is an author at Deutschen Konsortium für Translationale Krebsforschung specializing in immunology, medicine, and covid-19.

Top concepts

Publications per year

2017–2023

9

Publications

9

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 630 citations

, , +2

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 268 citations · Full text

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann et al. · Science Translational Medicine · 2021 · 166 citations · Full text

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Tatjana Bilich, Annika Nelde, Leon Bichmann et al. · Blood · 2018 · 75 citations · Full text

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Jens Bauer, Natalie Köhler, Yacine Maringer et al. · Nature Communications · 2022 · 66 citations · Full text

Rows per page

1–5 of 9